首页 > 最新文献

Animal Experimentation: Working Towards a Paradigm Change最新文献

英文 中文
Rethinking the 3Rs: From Whitewashing to Rights 重新思考3r:从洗白到权利
Pub Date : 2019-04-17 DOI: 10.1163/9789004391192_007
C. Blattner
Few other issues have prompted as many legislators to adopt legal instruction on the "proper" use of non-human animals (hereinafter referred to as animals) in medical and scientific research. Today, the 3Rs ( replacement, reduction, and refinement of animals in scientific procedures) are globally accepted by a vast majority of states (Blattner, 2014); and prominent international organizations, such as the World Organisation for Animal Health (Terrestrial Animal Health Code, 2018, Article 7(8)(3)) and the Council of Europe (Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes, 1986, Articles 6(2), 7 and 8). Widespread acceptance of the 3Rs is a notable achievement, since animal law is a relatively young field oflaw, and at­ titudes about the human-animal relationship diverge sharply across societies. As progressive as this established body of law appears, the rules govern­ ing research on animals-especially the 3R maxim that dominate this legal landscape-suffer from regulatory failure. First, and most importantly, de­ spite widespread commitment to replace and reduce animals in research, the number of animals used for experimental purposes worldwide is now the same as it was in the 1980s ( the number dropped in the 1990s and 2000s but has been rising ever since; Bayne et al., 2015, p. 3; European Commission, 2013; Taylor, 2013; Taylor et al., 2008; Taylor and Rego, 2016). Second, though the principle of refinement demands that the severity of experiments be dimin­ ished, countries are reporting a rising number of research procedures done on animals who are forced to endure the most severe experiments ( e.g., Neue Zurcher Zeitung, 2016). There is reason to believe that refinement, which seeks to ameliorate the conditions of animals used for a research procedure, fails to fulfill their basic welfare needs. For example, pursuant to the United States' Guide for the Care and Use of Laboratory Animals, a pig who weighs up to 50kg can be housed for up to five years on 15 square feet ( o.gm2), without any
很少有其他问题促使如此多的立法者通过关于在医学和科学研究中"适当"使用非人类动物(以下简称动物)的法律指示。如今,3r(在科学程序中替换、减少和改良动物)已被全球绝大多数国家所接受(Blattner, 2014);以及著名的国际组织,如世界动物卫生组织(陆生动物卫生法,2018年,第7(8)(3)条)和欧洲委员会(保护用于实验和其他科学目的的脊椎动物公约,1986年,第6(2)、7和8条)。3r的广泛接受是一项显著成就,因为动物法是一个相对年轻的领域。不同社会对人与动物关系的看法也大相径庭。尽管这一已确立的法律体系看起来是进步的,但管理动物研究的规则——尤其是主导这一法律领域的3R准则——却存在监管失灵的问题。首先,也是最重要的是,尽管人们普遍承诺在研究中取代和减少动物,但现在世界范围内用于实验目的的动物数量与20世纪80年代相同(20世纪90年代和21世纪初,这一数字有所下降,但此后一直在上升;Bayne et al., 2015, p. 3;欧盟委员会,2013;泰勒,2013;Taylor et al., 2008;Taylor and Rego, 2016)。其次,尽管细化原则要求降低实验的严重度,但各国正在报告越来越多的动物研究程序,这些动物被迫忍受最严厉的实验(例如,Neue Zurcher Zeitung, 2016)。有理由相信,旨在改善用于研究程序的动物条件的改良未能满足它们的基本福利需求。例如,根据美国《实验室动物护理和使用指南》,一头体重达50公斤的猪可以在15平方英尺(0.52平方英尺)的空间里饲养长达5年,而不需要任何食物
{"title":"Rethinking the 3Rs: From Whitewashing to Rights","authors":"C. Blattner","doi":"10.1163/9789004391192_007","DOIUrl":"https://doi.org/10.1163/9789004391192_007","url":null,"abstract":"Few other issues have prompted as many legislators to adopt legal instruction on the \"proper\" use of non-human animals (hereinafter referred to as animals) in medical and scientific research. Today, the 3Rs ( replacement, reduction, and refinement of animals in scientific procedures) are globally accepted by a vast majority of states (Blattner, 2014); and prominent international organizations, such as the World Organisation for Animal Health (Terrestrial Animal Health Code, 2018, Article 7(8)(3)) and the Council of Europe (Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes, 1986, Articles 6(2), 7 and 8). Widespread acceptance of the 3Rs is a notable achievement, since animal law is a relatively young field oflaw, and at­ titudes about the human-animal relationship diverge sharply across societies. As progressive as this established body of law appears, the rules govern­ ing research on animals-especially the 3R maxim that dominate this legal landscape-suffer from regulatory failure. First, and most importantly, de­ spite widespread commitment to replace and reduce animals in research, the number of animals used for experimental purposes worldwide is now the same as it was in the 1980s ( the number dropped in the 1990s and 2000s but has been rising ever since; Bayne et al., 2015, p. 3; European Commission, 2013; Taylor, 2013; Taylor et al., 2008; Taylor and Rego, 2016). Second, though the principle of refinement demands that the severity of experiments be dimin­ ished, countries are reporting a rising number of research procedures done on animals who are forced to endure the most severe experiments ( e.g., Neue Zurcher Zeitung, 2016). There is reason to believe that refinement, which seeks to ameliorate the conditions of animals used for a research procedure, fails to fulfill their basic welfare needs. For example, pursuant to the United States' Guide for the Care and Use of Laboratory Animals, a pig who weighs up to 50kg can be housed for up to five years on 15 square feet ( o.gm2), without any","PeriodicalId":138056,"journal":{"name":"Animal Experimentation: Working Towards a Paradigm Change","volume":"247 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114435765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Ethics, Efficacy, and Decision-making in Animal Research 动物研究中的伦理、功效和决策
Pub Date : 2019-04-17 DOI: 10.1163/9789004391192_012
L. Hansen, K. Kosberg
Few would disagree with the ethical contention that if cruelty to animals is not wrong, then nothing is wrong. In fact, it is not only wrong, but in most states in the us, it is a crime, a felony no less. And yet, intentionally inflicting pain and suffering upon animals, which meets Webster's definition of cruelty, is routinely countenanced when vivisection (from the Latin vivi, to be alive, and secare, to cut) is performed under license for biomedical research. Decid­ ing to embrace, or reject, or limit animal research demands our best ethical judgment; and it is complicated by factual disputes over the extent to which it benefits human health. Three issues combining facts and ethics need to be considered. First, to what extent does animal research deliver on its promise to improve human health? Second, if the goal of public investment ( e.g., tax dollars spent by the National Institute of Health, NIH) on animal research is to improve human health, are we getting sufficient return for the billions spent,
很少有人会不同意这样的伦理观点:如果虐待动物没有错,那么就没有错。事实上,这不仅是错误的,而且在美国的大多数州,这是一种犯罪,一种重罪。然而,在生物医学研究许可下进行活体解剖(来自拉丁语vivi,活着,惊吓,切割)时,故意给动物施加痛苦和折磨,这符合韦伯斯特对残忍的定义,通常是被允许的。决定接受、拒绝或限制动物研究需要我们最好的道德判断;关于它对人类健康的益处程度的事实争议使它变得复杂。需要考虑事实与伦理相结合的三个问题。首先,动物研究在多大程度上实现了改善人类健康的承诺?第二,如果公共投资(例如,美国国立卫生研究院(NIH)在动物研究上花费的税款)的目标是改善人类健康,那么我们所花费的数十亿美元是否获得了足够的回报?
{"title":"Ethics, Efficacy, and Decision-making in Animal Research","authors":"L. Hansen, K. Kosberg","doi":"10.1163/9789004391192_012","DOIUrl":"https://doi.org/10.1163/9789004391192_012","url":null,"abstract":"Few would disagree with the ethical contention that if cruelty to animals is not wrong, then nothing is wrong. In fact, it is not only wrong, but in most states in the us, it is a crime, a felony no less. And yet, intentionally inflicting pain and suffering upon animals, which meets Webster's definition of cruelty, is routinely countenanced when vivisection (from the Latin vivi, to be alive, and secare, to cut) is performed under license for biomedical research. Decid­ ing to embrace, or reject, or limit animal research demands our best ethical judgment; and it is complicated by factual disputes over the extent to which it benefits human health. Three issues combining facts and ethics need to be considered. First, to what extent does animal research deliver on its promise to improve human health? Second, if the goal of public investment ( e.g., tax dollars spent by the National Institute of Health, NIH) on animal research is to improve human health, are we getting sufficient return for the billions spent,","PeriodicalId":138056,"journal":{"name":"Animal Experimentation: Working Towards a Paradigm Change","volume":"43 9","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"113991251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
When Is an Alternative Not an Alternative? Supporting Progress for Absolute Replacement of Animals in Science 什么时候一个选择不是一个选择?支持科学上绝对替代动物的进展
Pub Date : 2019-04-17 DOI: 10.1163/9789004391192_028
C. Redmond
Despite a great deal of talk about "alternatives" to animal testing, and "replac­ ing" animal use, there are no clearly agreed upon definitions for these terms. This has led to extensive numbers of animals used and accepted as "alterna­ tives"-including zebrafish, invertebrates, animal tissues, embryos, sera, and animals' eyes-despite the obvious fact that they will suffer and/or be killed for these methods. Instead, there is a confusing array of reference to live ani­ mals, vertebrates, and mammals being termed as "less sentient" or "conscious" species. Much of the discussion on alternatives is still based around Russell and Burch's (1959) 3Rs; although few, if any, of the definitions currently in use match their original writings, which were designed to be a foundation for fu­ ture discussions. In the European Union (Eu), Directive 2010/63/EU on the protection of animals used for scientific purposes defines its aim as represent­ ing "an important step towards achieving the final goal of full replacement of procedures on live animals for scientific and educational purposes, as soon as it is scientifically possible to do so" (European Parliament, 2010, Recital 10 ). Al­ though this is a progressive step forward compared to previous legislation, use of the word live is often overlooked, as are so many other obstacles to a true end to all animal use in laboratory research. Talk of "replacing animal testing" and "alternatives" comes with little discussion about what those phrases actually mean; while researchers continue to use animal sera, tissues, and live animals that are perceived as less sentient. This chapter addresses some of the areas in which animals are still used within "alternatives" -based research and calls on animal welfare and in vitro or­ ganizations to lead the debate and encourage absolute replacement of animal
尽管关于动物试验的“替代品”和“替代”动物试验的讨论很多,但对这些术语的定义并没有明确的一致意见。这导致大量动物被用作“替代品”——包括斑马鱼、无脊椎动物、动物组织、胚胎、血清和动物的眼睛——尽管这些方法会使它们遭受痛苦和/或被杀死。相反,有一系列令人困惑的参考资料,将活体动物、脊椎动物和哺乳动物称为“没有知觉”或“有意识”的物种。关于替代方案的大部分讨论仍然基于罗素和伯奇(1959)的3r;虽然目前使用的定义很少(如果有的话)与他们的原始著作相匹配,这些著作被设计为将来讨论的基础。在欧盟(Eu),关于保护用于科学目的的动物的指令2010/63/ Eu将其目标定义为“在科学可行的情况下,朝着实现完全替代用于科学和教育目的的活体动物程序的最终目标迈出了重要的一步”(欧洲议会,2010,Recital 10)。尽管与以前的立法相比,这是一个进步的一步,但“活”这个词的使用经常被忽视,就像在实验室研究中真正结束所有动物使用的许多其他障碍一样。谈论“替代动物试验”和“替代品”时,很少有人讨论这些短语的实际含义;而研究人员继续使用动物血清、组织和被认为没有知觉的活体动物。本章讨论了在“替代品”研究中仍然使用动物的一些领域,并呼吁动物福利和体外实验组织领导辩论,鼓励绝对替代动物
{"title":"When Is an Alternative Not an Alternative? Supporting Progress for Absolute Replacement of Animals in Science","authors":"C. Redmond","doi":"10.1163/9789004391192_028","DOIUrl":"https://doi.org/10.1163/9789004391192_028","url":null,"abstract":"Despite a great deal of talk about \"alternatives\" to animal testing, and \"replac­ ing\" animal use, there are no clearly agreed upon definitions for these terms. This has led to extensive numbers of animals used and accepted as \"alterna­ tives\"-including zebrafish, invertebrates, animal tissues, embryos, sera, and animals' eyes-despite the obvious fact that they will suffer and/or be killed for these methods. Instead, there is a confusing array of reference to live ani­ mals, vertebrates, and mammals being termed as \"less sentient\" or \"conscious\" species. Much of the discussion on alternatives is still based around Russell and Burch's (1959) 3Rs; although few, if any, of the definitions currently in use match their original writings, which were designed to be a foundation for fu­ ture discussions. In the European Union (Eu), Directive 2010/63/EU on the protection of animals used for scientific purposes defines its aim as represent­ ing \"an important step towards achieving the final goal of full replacement of procedures on live animals for scientific and educational purposes, as soon as it is scientifically possible to do so\" (European Parliament, 2010, Recital 10 ). Al­ though this is a progressive step forward compared to previous legislation, use of the word live is often overlooked, as are so many other obstacles to a true end to all animal use in laboratory research. Talk of \"replacing animal testing\" and \"alternatives\" comes with little discussion about what those phrases actually mean; while researchers continue to use animal sera, tissues, and live animals that are perceived as less sentient. This chapter addresses some of the areas in which animals are still used within \"alternatives\" -based research and calls on animal welfare and in vitro or­ ganizations to lead the debate and encourage absolute replacement of animal","PeriodicalId":138056,"journal":{"name":"Animal Experimentation: Working Towards a Paradigm Change","volume":"102 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130798835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Refinement on the Way Towards Replacement: Are We Doing What We Can? 在替代之路上的改进:我们是否在尽我们所能?
Pub Date : 2019-04-17 DOI: 10.1163/9789004391192_002
Kathrin Herrmann
Russell and Burch introduced the principles of replacement, reduction, and refinement of animal experimentation in 1959 in their groundbreaking book, The Principles of Humane Experimental Technique, to eradicate inhumanity to­ wards non-human animals (hereinafter referred to as animals). They utilized the term inhumanity to indicate negative mental states experienced by animals used in research and the procedures that cause such mental states. Their goal was to avoid the use of animals wherever possible and to improve significantly the treatment of the animals still deemed indispensable, while improving the quality of scientific and medical research and testing (Russell and Burch, 1959 ). Since the 1990s, the 3Rs have slowly gained more acceptance within the animal research community. They have been recognized by organizations such as the Council of Europe (1986) and the World Organisation for Animal Health (2018), and they have been implemented in law in several countries, for example in Germany and in the UK (Herrmann, Kopemik and Biedermann, 2009; Zurlo, Rudacille and Goldberg, 1996). Today, the principles are not only embedded in legislation in the European Union (Eu) but around the world (Bayne et al., 2015). In the EU, Directive 2010/63/EU on the protection of animals used for scientific purposes came into effect in 2013, thereby requiring all EU Member States to implement the
1959年,罗素和伯奇在他们开创性的著作《人道实验技术的原则》中介绍了替代、减少和改进动物实验的原则,以消除对非人类动物(以下简称动物)的不人道行为。他们使用“不人道”一词来表示研究中使用的动物所经历的消极精神状态以及导致这种精神状态的程序。他们的目标是尽可能避免使用动物,并在提高科学和医学研究和测试质量的同时,显著改善仍然被认为是必不可少的动物的待遇(Russell and Burch, 1959)。自20世纪90年代以来,3r逐渐在动物研究界获得了更多的认可。它们已得到欧洲委员会(1986年)和世界动物卫生组织(2018年)等组织的认可,并已在几个国家(例如德国和联合王国)的法律中得到实施(Herrmann、Kopemik和Biedermann, 2009年;Zurlo, Rudacille和Goldberg, 1996)。今天,这些原则不仅被纳入欧盟(Eu)的立法,而且被纳入世界各地的立法(Bayne et al., 2015)。在欧盟,关于保护用于科学目的的动物的指令2010/63/EU于2013年生效,从而要求所有欧盟成员国实施
{"title":"Refinement on the Way Towards Replacement: Are We Doing What We Can?","authors":"Kathrin Herrmann","doi":"10.1163/9789004391192_002","DOIUrl":"https://doi.org/10.1163/9789004391192_002","url":null,"abstract":"Russell and Burch introduced the principles of replacement, reduction, and refinement of animal experimentation in 1959 in their groundbreaking book, The Principles of Humane Experimental Technique, to eradicate inhumanity to­ wards non-human animals (hereinafter referred to as animals). They utilized the term inhumanity to indicate negative mental states experienced by animals used in research and the procedures that cause such mental states. Their goal was to avoid the use of animals wherever possible and to improve significantly the treatment of the animals still deemed indispensable, while improving the quality of scientific and medical research and testing (Russell and Burch, 1959 ). Since the 1990s, the 3Rs have slowly gained more acceptance within the animal research community. They have been recognized by organizations such as the Council of Europe (1986) and the World Organisation for Animal Health (2018), and they have been implemented in law in several countries, for example in Germany and in the UK (Herrmann, Kopemik and Biedermann, 2009; Zurlo, Rudacille and Goldberg, 1996). Today, the principles are not only embedded in legislation in the European Union (Eu) but around the world (Bayne et al., 2015). In the EU, Directive 2010/63/EU on the protection of animals used for scientific purposes came into effect in 2013, thereby requiring all EU Member States to implement the","PeriodicalId":138056,"journal":{"name":"Animal Experimentation: Working Towards a Paradigm Change","volume":"222 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133422663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
The Moral Status of Animal Research Subjects in Industry: A Stakeholder Analysis 产业中动物研究主体的道德地位:利益相关者分析
Pub Date : 2019-04-17 DOI: 10.1163/9789004391192_009
Sarah Kenehan
The use of non-human animals (hereinafter referred to as animals) in research and testing is a widely accepted practice in many industries. Millions of ani­ mals each year are subjected to painful procedures that include everything from physical mutilation to drug addiction. According to the United States Department of Agriculture (USDA), over 820,812 animals were experimented on in the United States in 2016 (USDA, 2017), though this count does not in­ clude rats, mice, or birds, and dubiously relies solely on the self-reporting of laboratories (Humane Society of the United States, 2011; Keen, 2019, Chapter 10 in this Volume). Estimates suggest that a more accurate count one that includes rats, mice, and birds brings the number closer to 25 million total animals used in the United States (Humane Society of the United States, 2013). These numbers raise many questions, not least of which is whether this prac­ tice is prima facie immoral. But this is not the broader question that I address in this chapter. Instead, I look at the continued use of animals for experiments from the point of view of business ethics, in particular, through the lens of stakeholder theory. Specifically, I argue that animals as research subjects are stakeholders in the corporations that practice animal experimentation, and this status demands that their interests be considered with the interests of other stakeholders. Importantly, while this chapter discusses issues of interest to a broader phi­ losophy audience, it is, nonetheless, situated in a volume whose purpose is, in part, to motivate practical paradigm change in the way that animal advocates think about their work. Not unlike other scholars, my own work is shaped by my personal experiences: I am a philosopher by training and an animal advocate outside the walls of the academy, so my concern for animals is both theoretical and pragmatic. As such, the practical import of this chapter speaks most obvi­ ously to people like me, i.e., advocates who are also academics. In particular,
在研究和试验中使用非人类动物(以下简称动物)是许多行业广泛接受的做法。每年都有数以百万计的动物遭受痛苦的手术,从身体残缺到吸毒成瘾,无所不包。根据美国农业部(USDA)的数据,2016年在美国进行了超过820,812只动物实验(USDA, 2017),尽管这一数字不包括大鼠,小鼠或鸟类,并且完全依赖于实验室的自我报告(美国人道协会,2011;Keen, 2019,本卷第10章)。据估计,如果把老鼠、老鼠和鸟类也计算在内,那么美国使用的动物总数将接近2500万只(美国人道协会,2013年)。这些数字引发了许多问题,尤其是这种做法是否从表面上看是不道德的。但这不是我在本章要讨论的更广泛的问题。相反,我从商业伦理的角度,特别是通过利益相关者理论的视角,来看待继续使用动物进行实验的问题。具体来说,我认为作为研究对象的动物是进行动物实验的公司的利益相关者,这种地位要求将它们的利益与其他利益相关者的利益结合起来考虑。重要的是,虽然这一章讨论的是更广泛的哲学读者感兴趣的问题,但它的目的是,在某种程度上,激发动物倡导者思考他们工作的方式的实际范式改变。与其他学者一样,我自己的工作是由我的个人经历塑造的:我是一名训练有素的哲学家,在学院的围墙之外是一名动物倡导者,所以我对动物的关注既是理论的,也是实际的。因此,这一章的实际意义对像我这样的人来说是最明显的,即倡导者也是学者。特别是,
{"title":"The Moral Status of Animal Research Subjects in Industry: A Stakeholder Analysis","authors":"Sarah Kenehan","doi":"10.1163/9789004391192_009","DOIUrl":"https://doi.org/10.1163/9789004391192_009","url":null,"abstract":"The use of non-human animals (hereinafter referred to as animals) in research and testing is a widely accepted practice in many industries. Millions of ani­ mals each year are subjected to painful procedures that include everything from physical mutilation to drug addiction. According to the United States Department of Agriculture (USDA), over 820,812 animals were experimented on in the United States in 2016 (USDA, 2017), though this count does not in­ clude rats, mice, or birds, and dubiously relies solely on the self-reporting of laboratories (Humane Society of the United States, 2011; Keen, 2019, Chapter 10 in this Volume). Estimates suggest that a more accurate count one that includes rats, mice, and birds brings the number closer to 25 million total animals used in the United States (Humane Society of the United States, 2013). These numbers raise many questions, not least of which is whether this prac­ tice is prima facie immoral. But this is not the broader question that I address in this chapter. Instead, I look at the continued use of animals for experiments from the point of view of business ethics, in particular, through the lens of stakeholder theory. Specifically, I argue that animals as research subjects are stakeholders in the corporations that practice animal experimentation, and this status demands that their interests be considered with the interests of other stakeholders. Importantly, while this chapter discusses issues of interest to a broader phi­ losophy audience, it is, nonetheless, situated in a volume whose purpose is, in part, to motivate practical paradigm change in the way that animal advocates think about their work. Not unlike other scholars, my own work is shaped by my personal experiences: I am a philosopher by training and an animal advocate outside the walls of the academy, so my concern for animals is both theoretical and pragmatic. As such, the practical import of this chapter speaks most obvi­ ously to people like me, i.e., advocates who are also academics. In particular,","PeriodicalId":138056,"journal":{"name":"Animal Experimentation: Working Towards a Paradigm Change","volume":"47 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124666276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Increasing the Transparency of Animal Experimentation: An Australian Perspective 增加动物实验的透明度:澳大利亚的观点
Pub Date : 2019-04-17 DOI: 10.1163/9789004391192_010
Monika Merkes, Rob Buttrose
It has been argued that citizen stakeholders would be well served by greater transparency. The Transparency Register of the European Union (eu) (2016), for example, states that “Transparency is [...] a key part of encouraging European citizens to participate more actively in the democratic life of the eu”. But why is transparency in non-human animal (hereinafter referred to as animal) research desirable, or indeed vital? Hadley (2012) argues that the public finance much animal research but do not know what impact their taxes and donations have on animals. Furthermore, he suggests that, since “people enjoy the benefits of animal research when they consume pharmaceuticals or undergo surgical procedures that prolong or improve the quality of their lives, it seems reasonable to inform them of the costs to animals for which their consumer choices are to some extent causally responsible” (Hadley, 2012, p. 105). Good governance is another reason for transparency in animal research. Thus, McLeod and Hobson-West suggest that one of the key themes “in the science governance literature is the linking of transparency and public trust (or mistrust)” (2015, p. 792). Varga et al. concur that “more transparency will increase
有人认为,更大的透明度将更好地服务于公民利益相关者。例如,欧盟(eu)透明度登记册(2016)指出,“透明度是……[这是鼓励欧洲公民更积极地参与欧盟民主生活的关键部分]。但为什么非人类动物(以下简称动物)研究的透明度是可取的,或者确实是至关重要的?Hadley(2012)认为,公共财政资助了很多动物研究,但不知道他们的税收和捐赠对动物有什么影响。此外,他认为,既然“人们在消费药物或接受延长或改善生命质量的外科手术时享受动物研究的好处,那么告知他们他们的消费选择在某种程度上负有因果责任的动物成本似乎是合理的”(Hadley, 2012, p. 105)。良好的管理是动物研究透明化的另一个原因。因此,麦克劳德和霍布森-韦斯特认为,“科学治理文献中的关键主题之一是透明度与公众信任(或不信任)的联系”(2015年,第792页)。Varga等人同意“更多的透明度将会增加
{"title":"Increasing the Transparency of Animal Experimentation: An Australian Perspective","authors":"Monika Merkes, Rob Buttrose","doi":"10.1163/9789004391192_010","DOIUrl":"https://doi.org/10.1163/9789004391192_010","url":null,"abstract":"It has been argued that citizen stakeholders would be well served by greater transparency. The Transparency Register of the European Union (eu) (2016), for example, states that “Transparency is [...] a key part of encouraging European citizens to participate more actively in the democratic life of the eu”. But why is transparency in non-human animal (hereinafter referred to as animal) research desirable, or indeed vital? Hadley (2012) argues that the public finance much animal research but do not know what impact their taxes and donations have on animals. Furthermore, he suggests that, since “people enjoy the benefits of animal research when they consume pharmaceuticals or undergo surgical procedures that prolong or improve the quality of their lives, it seems reasonable to inform them of the costs to animals for which their consumer choices are to some extent causally responsible” (Hadley, 2012, p. 105). Good governance is another reason for transparency in animal research. Thus, McLeod and Hobson-West suggest that one of the key themes “in the science governance literature is the linking of transparency and public trust (or mistrust)” (2015, p. 792). Varga et al. concur that “more transparency will increase","PeriodicalId":138056,"journal":{"name":"Animal Experimentation: Working Towards a Paradigm Change","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128519767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Wasted Money in United States Biomedical and Agricultural Animal Research 美国生物医学和农业动物研究中浪费的资金
Pub Date : 2019-04-17 DOI: 10.1163/9789004391192_011
J. Keen
Biomedical and agricultural animal research uses millions of experimental animals and dozens of animal species each year by choice, precedent, or regu­ latory mandate in basic and applied life science research and toxicity testing of drugs, chemicals, and consumer products. Animal research is a large compo­ nent of the international us$270 billion government-subsidized, biomedical industrial ecosystem (Chakma et al., 2014). In the United States (us) and pre­ sumably elsewhere, about half of these funds support animal research and testing (Institute of Medicine and National Research Council, 2012 ). Each year at least 115 million experimental animals (mostly mice and likely a sig­ nificant underestimate) are used worldwide (Akhtar, 2015). The status quo ani­ mal research environment provides "ecosystem services" to a large number of inter-dependent "species", including governments, academia, biotechnology, agri-food and pharmaceutical industries, and publishers. Losers in this system are the conscripted animals (for "labor") and taxpayers (for "capital"). Animal research squanders precious public and private monies directly, in­ directly, by opportunity cost, and by unintended negative consequences. There is no doubt that biomedical and agricultural animal research have delivered societal dividends. Nevertheless, the questionable benefit-cost ratio and the unquestionable negative repercussions of animal research are enormous for taxpayers, patients, and the public at large. Precise animal research investments and attendant waste are impossible to ascertain, in part because the research community and the us government obfuscate financial and animal use data. However, estimated us tax dollars wasted on animal use in biomedical and
生物医学和农业动物研究每年在基础和应用生命科学研究以及药物、化学品和消费品的毒性测试中,根据选择、先例或监管要求,使用数百万只实验动物和数十种动物。动物研究是2700亿美元政府补贴的国际生物医学产业生态系统的重要组成部分(Chakma et al., 2014)。在美国,大概还有其他地方,大约一半的资金支持动物研究和试验(医学研究所和国家研究委员会,2012)。全世界每年至少使用1.15亿只实验动物(主要是小鼠,可能严重低估)(Akhtar, 2015年)。现状的研究环境为大量相互依赖的“物种”提供了“生态系统服务”,包括政府、学术界、生物技术、农业食品和制药工业以及出版商。在这个体系中,输家是被征召入伍的动物(代表“劳动”)和纳税人(代表“资本”)。动物研究直接、间接地、通过机会成本和意想不到的负面后果浪费了宝贵的公共和私人资金。毫无疑问,生物医学和农业动物研究已经带来了社会红利。然而,对纳税人、病人和广大公众来说,动物研究的收益成本比和负面影响是巨大的。精确的动物研究投资和随之而来的浪费是不可能确定的,部分原因是研究界和美国政府混淆了金融和动物使用数据。然而,据估计,美国税款浪费在生物医学和
{"title":"Wasted Money in United States Biomedical and Agricultural Animal Research","authors":"J. Keen","doi":"10.1163/9789004391192_011","DOIUrl":"https://doi.org/10.1163/9789004391192_011","url":null,"abstract":"Biomedical and agricultural animal research uses millions of experimental animals and dozens of animal species each year by choice, precedent, or regu­ latory mandate in basic and applied life science research and toxicity testing of drugs, chemicals, and consumer products. Animal research is a large compo­ nent of the international us$270 billion government-subsidized, biomedical industrial ecosystem (Chakma et al., 2014). In the United States (us) and pre­ sumably elsewhere, about half of these funds support animal research and testing (Institute of Medicine and National Research Council, 2012 ). Each year at least 115 million experimental animals (mostly mice and likely a sig­ nificant underestimate) are used worldwide (Akhtar, 2015). The status quo ani­ mal research environment provides \"ecosystem services\" to a large number of inter-dependent \"species\", including governments, academia, biotechnology, agri-food and pharmaceutical industries, and publishers. Losers in this system are the conscripted animals (for \"labor\") and taxpayers (for \"capital\"). Animal research squanders precious public and private monies directly, in­ directly, by opportunity cost, and by unintended negative consequences. There is no doubt that biomedical and agricultural animal research have delivered societal dividends. Nevertheless, the questionable benefit-cost ratio and the unquestionable negative repercussions of animal research are enormous for taxpayers, patients, and the public at large. Precise animal research investments and attendant waste are impossible to ascertain, in part because the research community and the us government obfuscate financial and animal use data. However, estimated us tax dollars wasted on animal use in biomedical and","PeriodicalId":138056,"journal":{"name":"Animal Experimentation: Working Towards a Paradigm Change","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131296098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Recent Developments in Alternatives to Animal Testing 动物试验替代品的最新发展
Pub Date : 2019-04-17 DOI: 10.1163/9789004391192_025
Katy Taylor
At least 115 million animals are thought to be used for scientific purposes every year, worldwide (Taylor et al., 2008). Animals are typically used to test whether an intervention will cause harm to humans or other animals of the same or different species, i.e. safety testing; or whether it will work, i.e. efficacy test­ ing. Interventions can include testing substances (such as cosmetic products, industrial chemicals, drugs, pesticides, food additives, and biocides ); medical devices; surgical techniques; environmental changes; or other ways of altering the physiology and/or behavior of a live animal. Safety testing is highly regu­ lated and is often done after any efficacy testing, if necessary, to finally check that an intervention is safe for humans and/or other animals to use. Efficacy testing is less formalized and often occurs in universities as ideas are tested in live animals as a "proof of concept", often prior to the development of actual interventions to help humans or other animals. Methods that replace techniques that use live animals, or methods of test­ ing substances without live animal use, are known as alternatives, replacements or non-animal methods. Some prefer the term advanced technologies given the fact that they often rely on more sophisticated technology and are more hu­ man-relevant than the animal test they replace (see Langley et al., 2015). There have been efforts to replace animal tests since the 1960s. Significant progress initially came in replacing animals used to diagnose human disease; to produce biological drugs ( such as vaccines); and to safety test batches of these drugs as they were produced. Concerns about safety were the initial driver for this, as drugs produced using animal material could be contaminated with animal diseases. However, cost, efficiency, and the need for swifter and more accurate predictions also played a part. Some of the earliest replacements are, in fact, no longer referred to as such, as they are now standard practice. For example, the
据认为,全世界每年至少有1.15亿只动物被用于科学目的(Taylor et al., 2008)。动物通常用于测试干预措施是否会对人类或其他相同或不同物种的动物造成伤害,即安全性测试;或者它是否会起作用,即功效测试。干预措施可包括检测物质(如化妆品、工业化学品、药物、农药、食品添加剂和杀菌剂);医疗设备;外科技术;环境变化;或其他改变活体动物生理和/或行为的方法。安全测试是高度规范的,通常在任何有效性测试之后进行,如果有必要,最终检查干预措施对人类和/或其他动物使用是安全的。有效性测试不太正式,通常在大学里进行,因为在开发实际干预措施以帮助人类或其他动物之前,将想法作为“概念证明”在活体动物身上进行测试。替代使用活体动物的技术的方法,或不使用活体动物的物质测试方法,被称为替代、替代或非动物方法。有些人更喜欢“先进技术”一词,因为它们往往依赖于更复杂的技术,与它们所取代的动物试验相比,它们与人的关系更密切(见Langley等人,2015)。自20世纪60年代以来,人们一直在努力取代动物实验。最初取得重大进展的是取代用于诊断人类疾病的动物;生产生物药品(如疫苗);并在这些药物生产时进行安全测试。对安全性的担忧是最初的驱动因素,因为使用动物材料生产的药物可能被动物疾病污染。然而,成本、效率以及对更快、更准确预测的需求也起到了一定作用。事实上,一些最早的替换已经不再这样称呼了,因为它们现在是标准做法。例如,
{"title":"Recent Developments in Alternatives to Animal Testing","authors":"Katy Taylor","doi":"10.1163/9789004391192_025","DOIUrl":"https://doi.org/10.1163/9789004391192_025","url":null,"abstract":"At least 115 million animals are thought to be used for scientific purposes every year, worldwide (Taylor et al., 2008). Animals are typically used to test whether an intervention will cause harm to humans or other animals of the same or different species, i.e. safety testing; or whether it will work, i.e. efficacy test­ ing. Interventions can include testing substances (such as cosmetic products, industrial chemicals, drugs, pesticides, food additives, and biocides ); medical devices; surgical techniques; environmental changes; or other ways of altering the physiology and/or behavior of a live animal. Safety testing is highly regu­ lated and is often done after any efficacy testing, if necessary, to finally check that an intervention is safe for humans and/or other animals to use. Efficacy testing is less formalized and often occurs in universities as ideas are tested in live animals as a \"proof of concept\", often prior to the development of actual interventions to help humans or other animals. Methods that replace techniques that use live animals, or methods of test­ ing substances without live animal use, are known as alternatives, replacements or non-animal methods. Some prefer the term advanced technologies given the fact that they often rely on more sophisticated technology and are more hu­ man-relevant than the animal test they replace (see Langley et al., 2015). There have been efforts to replace animal tests since the 1960s. Significant progress initially came in replacing animals used to diagnose human disease; to produce biological drugs ( such as vaccines); and to safety test batches of these drugs as they were produced. Concerns about safety were the initial driver for this, as drugs produced using animal material could be contaminated with animal diseases. However, cost, efficiency, and the need for swifter and more accurate predictions also played a part. Some of the earliest replacements are, in fact, no longer referred to as such, as they are now standard practice. For example, the","PeriodicalId":138056,"journal":{"name":"Animal Experimentation: Working Towards a Paradigm Change","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132002044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
How Can the Final Goal of Completely Replacing Animal Procedures Successfully Be Achieved? 如何才能成功实现完全替代动物手术的最终目标?
Pub Date : 2019-04-17 DOI: 10.1163/9789004391192_004
Christiane Baumgartl-Simons, Christiane D. Hohensee
2373. [ online] Available at: https:/ /www.mattek.com/reference-library/ identification-of-endocrine-disruptors-using-an-organotypic-vaginal-tissue­ model/ [Accessed 6 August 2017 ]. Ayehunie, S., Landry, T., Hayden, P. and Klausner M. ( 2016 ). Pre-validation of in vitro in vivo assays for vaginal irritation. In: Society of Toxicology 2016 Annual Meeting. [ online] Available at: https:/ /www.mattek.com/join-us-at-sot-2016/ [ Accessed 6 August 2017 ] . Baumgartl-Simons, C. (2017). Das Ende muss endlich wirksam verfolgt werden. Tierrechte, 02, p. 4. [ online] Available at: https:/ /www.tierrechte.de/images/stories/ Presse_und_Magazin_Tierrechte/Magazin_2-17 _.pdf [ Accessed nJanuary 2018] . BfR(2017a) .NationalerAusschussTierschutzgesetz-EJR. [ online ]Availableat:http:/ /www .bfr.bund.de/ de/nationaler_ausschuss_tierschutzgesetz.html [ Accessed 2 August 2017] . Kathrin Herrmann and Kimberley Jayne 978-90-04-39119-2 Downloaded from Brill.com11 /11 /2019 09:57:0BPM via free access 116 BAUMGARTL-SIMONS AND HOHENSEE BfR (2017b). Fragen und Antworten zum Deutschen Zentrum zum Schutz von Versuch­ stieren (B/3R). [ online] Available at: http://www.bfr.bund.de/cm/343/fragen-und­ antworten-zum-deutschen-zentrum-zum-schutz-von-versuchstieren-bf3r.pdf [ Accessed 4 August 2017 ] . BMBF (20n). Bekanntmachung des Bundesministeriums far Bi/dung und Forschung von Richtlinien zur Forderung ,,e:Bio lnnovationswettbewerb Systembiologie" Vom 17. Dezember 2010. [ online] Available at: https:/ /www.bmbf.de/foerderungen/ bekanntmachung.php?B=6o8 [ Accessed 4 August 2017 ] . BMBF (2015a). Bekanntmachung des Bundesministeriumsfar Bildung und Forschung von Richtlinien zur Forderung der "Multilateralen Zusammenarbeit in Computational Neuroscience: Deutsch/and USA Israel Frankreich" Vom 16. Juli 2015. [ online] Available at: https:/ /www.bmbf.de/foerderungen/bekanntmachung-1068.html [ Accessed 4 August 2017 ] . BMBF ( 2015b ). Bekanntmachung: Richtlinie zur Forderung von ''Altemativmethoden zum Tierversuch': Bundesanzeiger vom 24.12.2015. [ online] Available at: https:/ /www. bmbf.de/foerderungen/bekanntmachung.php?B=n24 [ Accessed 6 August 2017 ] . BMBF ( 2016). Lebenswissenschaftliche GrundlagenforschungALtemativenzum Tierver­ such. [ online] Available at: https:/ /www.bmbf.de/de/altemativen-zum-tierversuch -412.html [ Accessed 6 August 2017 ] . Buchmann Institute for Molecular Life Sciences (2017). BMLS Drug Delivery and 3R-models. [ online] Available at: https:/ /www.bmls.de/Drug_Delivery_and-3R­ Models/people.html [Accessed 6 August 2017 ] . Bundesministerium fiir Justiz und Verbraucherschutz ( 2017 ) . §46 TierSch Vers VEinzel­ norm. [ online] Available at: http://www.gesetze-im-intemet.de/tierschversv/_46. html [ Accessed 4 August 2017 ] . Bundesministerium fiir Wirtschaft und Energie (2017). Forderdatenbank Inhalts­ verzeichnis. [ online] Available at: http://www.foerderdatenbank.de/Foerder-DB/ Navigation/Foerderrecherche/inhaltsverzeichnis.html?get=ea6079646dcbaffo
2373. [在线]可在:https:/ /www.mattek.com/reference-library/ identified -of- endocrinedisruptors -using-an-organotypic-vaginal-tissue - model/[访问日期:2017年8月6日]。Ayehunie, S., Landry, T., Hayden, P.和Klausner M.(2016)。阴道刺激的体外体内试验的预验证。见:美国毒理学学会2016年年会。[在线]可在:https:/ /www.mattek.com/join-us-at-sot-2016/[2017年8月6日访问]。鲍姆加特-西蒙斯,C.(2017)。as Ende muss endlich workksam verfolgt werden。Tierrechte, 2002,第4页。[在线]可在:https:/ /www.tierrechte.de/images/stories/ Presse_und_Magazin_Tierrechte/ magazin_2 - 17_pdf[2018年1月访问]。BfR .NationalerAusschussTierschutzgesetz-EJR(2017)。[在线]可获取:http://www.bfr.bund.de/nationaler_ausschuss_tierschutzgesetz.html[访问日期:2017年8月2日]。116 baumgartt - simons and HOHENSEE BfR (2017b)。Fragen and Antworten zum Deutschen Zentrum zum Schutz von Versuch - stien (B/3R)。[在线]查阅:http://www.bfr.bund.de/cm/343/fragen-und - antworten-zum-deutschen-zentrum-zum-schutz-von-versuchstieren-bf3r.pdf[2017年8月4日访问]。BMBF (20 n)。[j] .中国生物医学工程学报,2011,(1):1 - 2。Dezember 2010。[在线]可在:https:/ /www.bmbf.de/foerderungen/ bekanntmachung.php?B= 608[2017年8月4日访问]。BMBF(2015)。《计算神经科学的多边化研究:德国/美国/以色列》,第16期。2015年朱莉。[在线]可在:https:/ /www.bmbf.de/foerderungen/bekanntmachung-1068.html[2017年8月4日访问]。BMBF (2015b)。《德国联邦分析》,2015年12月24日,《德国联邦分析》。[在线]可在:https:/ /www。bmbf.de/foerderungen/bekanntmachung.php?B=n24[访问日期:2017年8月6日]。BMBF(2016)。Lebenswissenschaftliche GrundlagenforschungALtemativenzum Tierver - such。[在线]可在:https:/ /www.bmbf.de/de/altemativen-zum-tierversuch -412.html[2017年8月6日访问]。布赫曼分子生命科学研究所(2017)。BMLS给药和3r模型。[在线]可在:https:/ /www.bmls.de/Drug_Delivery_and-3R - Models/people.html[访问日期:2017年8月6日]。联邦政府司法与Verbraucherschutz(2017)。§46 TierSch Vers VEinzel - norm。[在线]可在:http://www.gesetze-im-intemet.de/tierschversv/_46。[2017年8月4日访问]。德国联邦政府财政和能源(2017)。Forderdatenbank吸入- verzeichnis。[在线]可在:http://www.foerderdatenbank.de/Foerder-DB/ Navigation/Foerderrecherche/inhaltsverzeichnis.html?get= ea6079646dafa99d7 8c1252foafa99d6;views;document&doc=13310[访问日期:2017年8月4日]。CAAT (n.d.a.)。CAAT历史。[在线]可在:http://caat.jhsph.edu/about/history .html[2018年7月26日访问]。CAAT(未注明出处)关于我们:动物试验替代品中心。[在线]可在:http://caat.jhsph.edu/about/index.html[2018年7月26日访问]。Chen, S., S.E. Palma-Vera, M. Langhammer, S.P. Galuska, B.C. Braun, E。克劳斯,A.卢卡斯-哈恩和J.舍恩(2017)。早期胚胎-母体接触区的气-液间相模型。科学报告,7,42298[在线]可访问:https:/ /www.nature.com/articles/srep42298[2018年2月12日访问]。环境物质毒性测试和评估委员会(2007年)。21世纪毒性检测:展望与策略。[在线]来源:http://kathrin Herrmann and Kimberley Jayne 978-90-04-391192下载自brill.com 11/11/2019 09:57:0BPM免费获取如何实现完全取代动物的最终目标117 dels.nas.edu /resources/static-assets/ materials-bas--reports-inbrief / Toxicity_Testing_final.pdf[访问日期:2017年8月5日]。化妆品欧洲(2017)。促进科学研究。[在线]可在:https:/ / www.cosmeticseurope.eu/how-we-take-action/promoting-science-research/[2017年8月4日发布]。克罗宁,M.(2017)。非动物途径的前进之路。欧洲委员会科学会议报告。布鲁塞尔,比利时。2016年12月6日至7日。[在线]可在:http://ec.europa。eu/environment/chemicals/lab_animals/3r/ pdf/scientific_conference/non_animal_approaches_conference_report.pdf[访问日期:2018年7月26日]。柏林联邦参议院(2017)。参议院批准2018-2022年特许经营法案。Pressemitteilung[在线]可在:https:/ /www。Berlin.de /
{"title":"How Can the Final Goal of Completely Replacing Animal Procedures Successfully Be Achieved?","authors":"Christiane Baumgartl-Simons, Christiane D. Hohensee","doi":"10.1163/9789004391192_004","DOIUrl":"https://doi.org/10.1163/9789004391192_004","url":null,"abstract":"2373. [ online] Available at: https:/ /www.mattek.com/reference-library/ identification-of-endocrine-disruptors-using-an-organotypic-vaginal-tissue­ model/ [Accessed 6 August 2017 ]. Ayehunie, S., Landry, T., Hayden, P. and Klausner M. ( 2016 ). Pre-validation of in vitro in vivo assays for vaginal irritation. In: Society of Toxicology 2016 Annual Meeting. [ online] Available at: https:/ /www.mattek.com/join-us-at-sot-2016/ [ Accessed 6 August 2017 ] . Baumgartl-Simons, C. (2017). Das Ende muss endlich wirksam verfolgt werden. Tierrechte, 02, p. 4. [ online] Available at: https:/ /www.tierrechte.de/images/stories/ Presse_und_Magazin_Tierrechte/Magazin_2-17 _.pdf [ Accessed nJanuary 2018] . BfR(2017a) .NationalerAusschussTierschutzgesetz-EJR. [ online ]Availableat:http:/ /www .bfr.bund.de/ de/nationaler_ausschuss_tierschutzgesetz.html [ Accessed 2 August 2017] . Kathrin Herrmann and Kimberley Jayne 978-90-04-39119-2 Downloaded from Brill.com11 /11 /2019 09:57:0BPM via free access 116 BAUMGARTL-SIMONS AND HOHENSEE BfR (2017b). Fragen und Antworten zum Deutschen Zentrum zum Schutz von Versuch­ stieren (B/3R). [ online] Available at: http://www.bfr.bund.de/cm/343/fragen-und­ antworten-zum-deutschen-zentrum-zum-schutz-von-versuchstieren-bf3r.pdf [ Accessed 4 August 2017 ] . BMBF (20n). Bekanntmachung des Bundesministeriums far Bi/dung und Forschung von Richtlinien zur Forderung ,,e:Bio lnnovationswettbewerb Systembiologie\" Vom 17. Dezember 2010. [ online] Available at: https:/ /www.bmbf.de/foerderungen/ bekanntmachung.php?B=6o8 [ Accessed 4 August 2017 ] . BMBF (2015a). Bekanntmachung des Bundesministeriumsfar Bildung und Forschung von Richtlinien zur Forderung der \"Multilateralen Zusammenarbeit in Computational Neuroscience: Deutsch/and USA Israel Frankreich\" Vom 16. Juli 2015. [ online] Available at: https:/ /www.bmbf.de/foerderungen/bekanntmachung-1068.html [ Accessed 4 August 2017 ] . BMBF ( 2015b ). Bekanntmachung: Richtlinie zur Forderung von ''Altemativmethoden zum Tierversuch': Bundesanzeiger vom 24.12.2015. [ online] Available at: https:/ /www. bmbf.de/foerderungen/bekanntmachung.php?B=n24 [ Accessed 6 August 2017 ] . BMBF ( 2016). Lebenswissenschaftliche GrundlagenforschungALtemativenzum Tierver­ such. [ online] Available at: https:/ /www.bmbf.de/de/altemativen-zum-tierversuch -412.html [ Accessed 6 August 2017 ] . Buchmann Institute for Molecular Life Sciences (2017). BMLS Drug Delivery and 3R-models. [ online] Available at: https:/ /www.bmls.de/Drug_Delivery_and-3R­ Models/people.html [Accessed 6 August 2017 ] . Bundesministerium fiir Justiz und Verbraucherschutz ( 2017 ) . §46 TierSch Vers VEinzel­ norm. [ online] Available at: http://www.gesetze-im-intemet.de/tierschversv/_46. html [ Accessed 4 August 2017 ] . Bundesministerium fiir Wirtschaft und Energie (2017). Forderdatenbank Inhalts­ verzeichnis. [ online] Available at: http://www.foerderdatenbank.de/Foerder-DB/ Navigation/Foerderrecherche/inhaltsverzeichnis.html?get=ea6079646dcbaffo","PeriodicalId":138056,"journal":{"name":"Animal Experimentation: Working Towards a Paradigm Change","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114175529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Potential of Organ on Chip Technology for Replacing Animal Testing 器官芯片技术取代动物实验的潜力
Pub Date : 2019-04-17 DOI: 10.1163/9789004391192_027
M. Wilkinson
The term organ on a chip is used to describe the latest stage of development of in vitro cell culture technology. Figure 26.1 shows its steady development since the 1960s. Each step forward has improved our ability to model human-clinical response to new drugs or therapies and has enabled safety risk assessment of existing cosmetics, personal care products, or other chemicals in the environ­ ment. Scientific evidence that the predictive power of in vitro tests is superior to the use of animals will trigger a major shift in the way that medical research, in many areas, is carried out. In this emerging field, some researchers also refer to organ on a chip as a microphysiological system. As yet, there are few agreed upon standards or definitions for the latest developments .
“芯片上的器官”一词用来描述体外细胞培养技术的最新发展阶段。图26.1显示了20世纪60年代以来的稳定发展。每一步的进步都提高了我们模拟人类对新药或疗法的临床反应的能力,并使现有化妆品、个人护理产品或环境中其他化学物质的安全风险评估成为可能。科学证据表明,体外试验的预测能力优于动物试验,这将引发许多领域开展医学研究方式的重大转变。在这个新兴领域,一些研究人员也将芯片上的器官称为微生理系统。到目前为止,几乎没有就最新发展达成一致的标准或定义。
{"title":"The Potential of Organ on Chip Technology for Replacing Animal Testing","authors":"M. Wilkinson","doi":"10.1163/9789004391192_027","DOIUrl":"https://doi.org/10.1163/9789004391192_027","url":null,"abstract":"The term organ on a chip is used to describe the latest stage of development of in vitro cell culture technology. Figure 26.1 shows its steady development since the 1960s. Each step forward has improved our ability to model human-clinical response to new drugs or therapies and has enabled safety risk assessment of existing cosmetics, personal care products, or other chemicals in the environ­ ment. Scientific evidence that the predictive power of in vitro tests is superior to the use of animals will trigger a major shift in the way that medical research, in many areas, is carried out. In this emerging field, some researchers also refer to organ on a chip as a microphysiological system. As yet, there are few agreed upon standards or definitions for the latest developments .","PeriodicalId":138056,"journal":{"name":"Animal Experimentation: Working Towards a Paradigm Change","volume":"72 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124443084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
期刊
Animal Experimentation: Working Towards a Paradigm Change
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1